188 results on '"Martinez, Caridad A."'
Search Results
2. Prolonged Cytopenias after Immune Effector Cell Therapy and Lymphodepletion in Patients with Leukemia, Lymphoma, and Solid Tumors
3. Transient Generalized Osteosclerosis in a Newborn Mimicking Congenital Osteopetrosis with Negative Comprehensive Genetic Workup: A Case Report
4. Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc
5. Reduced Cumulative Dosing of Alemtuzumab in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Is Associated with Improved Long Term Survival
6. Analyzing the Effects of Obesity and Ethnicity on Outcomes of Pediatric Patients with Hematologic Malignancies Receiving Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide (PTCy): A Single Center Experience
7. Long-Term Follow-up of Outcomes of Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Retrospective Review
8. Long-Term Follow-up of Outcomes of Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia: A Single Center Retrospective Review Spanning More Than 25 Years.
9. Acute Exacerbation of Graft-versus-Host Disease following SARS-CoV2 infection after Hematopoietic Stem Cell Transplant in Two Pediatric Patients.
10. Incorporating a Race Equity Framework into Opioid Use Disorder Treatment
11. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab
12. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia
13. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
14. Co-occurring Psychiatric Disorders
15. Abstract 4 Excellent Event-Free-Survival and Immunoglobulin Independence for Patients with Severe Combined Immunodeficiency Transplanted with Umbilical Cord Blood Stem Cells
16. Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD
17. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
18. Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
19. The earlier, the better: RAG-deficient transplants
20. Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy
21. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions
22. Outcomes of Pediatric Bone Marrow Transplant Patients Receiving Palifermin with Melphalan-Based Conditioning Regimens
23. Incidence and Outcome of Secondary Graft Failure in Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Single Center Study
24. Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
25. 2161. Posoleucel, an Allogeneic, Off-the-Shelf Multi-Virus Specific T Cell Therapy, for Severe, Drug-Refractory Viral Infections in Pediatric Patients Following HCT: Results from a Phase 2 Trial
26. Teaching Motivational Interviewing
27. Fundamentals of Motivational Interviewing
28. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC
29. Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL
30. Acute exacerbation of graft‐versus‐host disease following SARS‐CoV2 infection after hematopoietic stem cell transplant in two pediatric patients
31. Outcomes after Hematopoietic Cell Transplant and Gene Therapy for Adenosine Deaminase (ADA) Severe Combined Immune Deficiency: A Combined Analysis from the Primary Immune Deficiency Treatment Consortium (PIDTC) 6901 and 6902 Studies
32. Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL
33. Safety and Tolerability of Administering Leukemia-Specific Donor T Cells (mLSTs) after Allogeneic Transplant to Pediatric Patients with AML/MDS
34. Xylitol in the Pediatric Hematopoietic Stem Cell Transplant Population: Quality Initiative to Decrease Bloodstream Infections
35. Hematopoietic Cell Transplantation in 240 Patients with Chronic Granulomatous Disease: A Pidtc Report
36. A Primary Immune Deficiency Treatment Consortium (PIDTC) Study of Chronic and Late Onset Medical Complications after Initial Hematopoietic Cell Transplantation (HCT) for Severe Combined Immunodeficiency Disease (SCID)
37. Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma
38. Plasma Metagenomic Sequencing Expedites Diagnosis of Disseminated BCG in an Infant With IKBKB Mutation
39. Acute Exacerbation of Graft-versus-Host Disease following SARS-CoV2 infection after Hematopoietic Stem Cell Transplant in Two Pediatric Patients
40. Guidelines for Pediatric Unrelated Cord Blood Transplantation—Unique Considerations
41. Severe Combined Immunodeficiency with De Novo Duchenne Muscular Dystrophy Mutation
42. HSCT corrects primary immunodeficiency and immune dysregulation in patients with POMP-related autoinflammatory disease
43. Rare Variant Genetic Association Study for Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Via Whole Exome Sequencing
44. Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL
45. 32.6 Comparing Efficacy of Psychotropic Medications to Control Agitation Among Pediatric Patients Hospitalized With ODD
46. Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children’s Hospital experience
47. Gastric Adenocarcinoma in the Setting of IPEX Syndrome
48. Long-read sequencing for diagnosis in the Undiagnosed Diseases Network
49. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Patients: A Single Institution Experience
50. Excellent Outcomes for Pediatric and Adult Patients with Hodgkin Lymphoma Receiving Rituximab As Adjunctive Therapy to BEAM Conditioning for Autologous Stem Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.